NR4A2 and Parkinson disease: LMX1A gene therapy: In DAnergic neuron development, Nurr1, Lmx1a, and Pitx3 are representative transcriptional factors that determine the developmental fate of DAnergic neurons and the expression of those factors is downregulated in the DAnergic neurons of PD patients [120].